IceCure reports full tumour reduction after six months in cryoablation study
ProSense uses extreme cold to destroy tumours, used as a minimally invasive alternative to surgery. Credit: Maskot via Getty Images. IceCure Medical’s cryoablation technology ProSense has demonstrated it can reduce breast cancer tumour sizes by 100% after 12 months, in an independent study. The 39-patient cohort was monitored one, three, six, and 12-months post-procedure after […]
DiaCarta, OncoAssure partner on prostate cancer test
The two companies intend to launch a lab-developed prostate cancer test. Credit: Michal Jarmoluk from Pixabay. Diagnostic companies DiaCarta and OncoAssure have announced a collaboration to launch a lab-developed test for prostate cancer. The collaboration aims to commercialise OncoAssure’s prostate cancer test, which is designed to help identify patients with a lower risk of recurrence […]
NHS England ramps up AI skin cancer tool rollout
According to GlobalData, there will be 222,458 cases of melanoma by 2029 in the eight major markets (UK, US, France, Spain, Italy, Germany, Canada, and Australia). Credit: goodluz via Shutterstock. The National Health Service (NHS) in the UK is funding nine trusts to pilot Skin Analytics’ artificial intelligence (AI) device for detecting cancerous skin legions. […]
Natera’s cancer detection test wins extended Medicare coverage
Circulating tumour DNA has become an important biomarker in cancer assessment. Image credit: Shutterstock/Meletios Verras. The Centers for Medicare & Medicaid Services (CMS) has signed off on Natera’s molecular residual disease (MRD) test for two new cancer indications, broadening access to the test to more US patients. Natera’s Signatera test is now covered in ovarian […]
UK’s adsilico raises $4.4m to develop virtual trial solution
In-silico trials, also known as simulated trials, use AI-assisted modelling and simulations to create a synthetic population that tests a particular medical device or drug. Image Credit: elenabsl / Shutterstock. UK University of Leeds spinout adsilico has raised £3.5m ($4.4m) in seed funding to develop an in-silico trial solution. The company received £2m in investment […]
Streamlining supply chain operations in focus at Clinical Trial Supply Europe 2024
Image credit: Arena International. How can true supply chain agility be achieved in response to increasingly complex trial demands? This question will be explored at the upcoming Clinical Trial Supply Europe 2024 conference, held on 6-7 April in Barcelona, Spain, where pharmaceutical companies and biotech’s will discuss and debate new technologies and processes aimed at […]
Laplace completes first human procedure with TTVR system
The procedure was performed at Tucson Medical Center, Arizona, US. Credit: MAD.vertise/ shutterstock.com. US-based medical device company Laplace Interventional has successfully completed the first-in-human procedure in an early feasibility study (EFS) with its TTVR system. The EFS clinical protocol is approved by the US Food and Drug Administration (FDA) and the procedure aims to evaluate […]
Zepp Health launches Zepp OS 3.5 with AI-powered Zepp Flow
The system enhances the way users interact with their smart devices, integrating artificial intelligence (AI) into everyday life seamlessly. Credit: LDprod/ shutterstock.com. Zepp Health, a provider of smart wearables and health technology, has launched an update to its health management platform, Zepp OS 3.5, featuring the AI-driven Zepp Flow, marking a significant advancement in wearable […]
University of Waterloo develops rapid opioid detection technique
The new method involves placing a small blood volume into a well plate containing a phosphate buffer. Credit: The University of Waterloo. Researchers at the University of Waterloo in Canada have developed a new blood testing technique that can identify the presence of potent opioids including the highly potent fentanyl in less than three minutes. […]
US FDA authorises Virtual Incision’s surgical robot
The company plans to undertake studies for gynaecological procedures in 2024 for the new miniRAS device. Credit: MVIDEOMEDIA/ shutterstock.com. The US Food and Drug Administration (FDA) has authorised the marketing of Virtual Incision’s MIRA Surgical System, a miniRAS device, for adult colectomy procedures. Featuring a compact size, the MIRA Surgical System weighs less than one […]